A careful pretransfusion testing and screening is significant, especially for transfusion-transmitting infections. [1] Hepatitis B is a major public health problem worldwide. Roughly, about 2 billion (30%) of the world's population present serological evidence of either a present or past infection with hepatitis B virus (HBV). [2] India is the second most populated country in the world. The Indian subcontinent is listed under intermediate HBV infection zone with 2%-7% of hepatitis B surface antigen (HbsAg) carriers. HBV occurs as the second most important cause of acute, subacute, and fulminant hepatitis in India. [3] The seroprevalence of HBsAg among blood donors is a major global and public health issue. HBV infection is one of the transfusion-transmissible infections; hence, it is essential to test all the blood donors for HBsAg. Serosurveys are Background: Hepatitis B infection is a serious global and public health problem. Hepatitis B is one among the transfusiontransmissible infections. Hepatitis B virus (HBV) is a DNA virus that causes acute and chronic liver diseases. Transmission of infection occurs through blood transfusion, needles, body fluids, and sexual intercourse. The clinical diagnosis of carrier state of HBV is commonly done by the detection of hepatitis B surface antigen (HBsAg) in the serum.The prevalence of this infection differs across the globe. The preventive strategies can be accomplished by analyzing the trends in seroprevalence. Objective: To assess the seroprevalence of HBsAg among blood donors attending the blood bank of a tertiary-care hospital. Materials and Methods: The study was conducted at the blood bank of Hassan Institute of Medical Sciences (a tertiarycare hospital), Hassan, Karnataka, India. In this retrospective study, healthy blood donors, over a period of 3 years from 2011 to 2013, were assessed. The blood donors were categorized as voluntary and replacement donors. Blood samples from donors were subjected to serological tests for the detection of HBsAg through ELISA-based assay. Result: A total of 11,894 blood donors were studied. Seventy-four (0.62%) cases were positive, which comes under the "low prevalence (<2%) zone" as per World Health Organization (WHO) guidelines. Male blood donors showed significantly higher seropositivity when compared with female donors. The c 2-test was used to calculate the significance of difference between the sex groups. Conclusion: This study endorses the fact that extensive screening through routine and specialized tests is mandatory, and definite criteria are to be given for the selection of donor to minimize the spread of HbsAg infection through transmission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.